Pilot Study on the Feasibility, Safety and Immunogenicity of a Personalized Neoantigen-Targeted Immunotherapy (NeoPepVac) in Combination with Anti-PD-1 or Anti-PD-L1 in Advanced Solid Tumors
Moerk, S.K., Donia, M., Kringelum, J.V., Bogenrieder, T., Rønø, B., Sorensen, A.B., Draghi, A., Bol, K.F., Petersen, N.V., Kadivar, M., Hernandez, S.S., Hadrup, S. Reker, Andreasen, L.V., Christensen, D., Andersen, P.L., Svane, I.M.
Published in Annals of oncology (01.12.2019)
Published in Annals of oncology (01.12.2019)
Get full text
Journal Article